Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
dc.contributor.author | Crowther, M | |
dc.contributor.author | Palumbo, Js | |
dc.contributor.author | Kumar, R | |
dc.contributor.author | Nurmeev, I | |
dc.contributor.author | Hege, K | |
dc.contributor.author | Bonnet, D | |
dc.contributor.author | Connor, P | |
dc.contributor.author | Hooimeijer, Hl | |
dc.contributor.author | Torres, M | |
dc.contributor.author | Chan, Akc | |
dc.contributor.author | Kenet, G | |
dc.contributor.author | Holzhauer, S | |
dc.contributor.author | Santamaría, A | |
dc.contributor.author | Amedro, P | |
dc.contributor.author | Chalmers, E | |
dc.contributor.author | Simioni, P | |
dc.contributor.author | Bhat, Rv | |
dc.contributor.author | Yee, Dl | |
dc.contributor.author | Lvova, O | |
dc.contributor.author | Beyer-Westendorf, J | |
dc.contributor.author | Massicotte, Mp | |
dc.contributor.author | Young, G | |
dc.contributor.author | Pap, Af | |
dc.contributor.author | Majumder, M | |
dc.contributor.author | Smith, Wt | |
dc.contributor.author | Heubach, Jf | |
dc.contributor.author | Berkowitz, Sd | |
dc.contributor.author | Thelen, K | |
dc.contributor.author | Kubitza, D | |
dc.contributor.author | Prins, Mh | |
dc.contributor.author | Monagle, P | |
dc.contributor.author | Eınsteın-Jr, Phase | |
dc.contributor.author | Kállay, K | |
dc.contributor.author | Gauger, Ca | |
dc.contributor.author | Biss, Tt | |
dc.contributor.author | Martinelli, I | |
dc.contributor.author | Saracco, P | |
dc.contributor.author | Peters, M | |
dc.contributor.author | Male, C | |
dc.contributor.author | Lensing, Awa | |
dc.date.accessioned | 2021-03-05T13:24:49Z | |
dc.date.available | 2021-03-05T13:24:49Z | |
dc.identifier.citation | Male C., Lensing A., Palumbo J., Kumar R., Nurmeev I., Hege K., Bonnet D., Connor P., Hooimeijer H., Torres M., et al., "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.", The Lancet. Haematology, cilt.7, 2020 | |
dc.identifier.issn | 2352-3026 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b2184c8f-cec2-45a3-bcb3-09c663a14a95 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/118647 | |
dc.identifier.uri | https://doi.org/10.1016/s2352-3026(19)30219-4 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. | |
dc.type | Makale | |
dc.relation.journal | The Lancet. Haematology | |
dc.contributor.department | , , | |
dc.identifier.volume | 7 | |
dc.contributor.firstauthorID | 2482026 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Makale [92796]